ZJ23F1001464
Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
Eculizumab (anti-Complement C5) - Primary antibody, specific to C5, >95%, high purity, Human IgG2+Human IgG4, INHIBITOR of Complement C5 inhibitor, INHIBITOR of Complement C5 inhibitor
- Host species: Human
- Reactive species: Human,Mouse
- Isotype: Human IgG2+Human IgG4
- Conjugation: Unconjugated
In stock
Item Number
Ab170870
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab170870-100μg
|
100μg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$99.90
|
|
|
Ab170870-1mg
|
1mg |
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
|
$477.90
|
|
|
Ab170870-5mg
|
5mg |
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
|
$1,437.90
|
|
|
Ab170870-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$2,277.90
|
|
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG2+Human IgG4; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated